Read the Journal of Managed Care + Specialty Pharmacy (JMCP) - September 2025 Issue
JMCP Findings: Payer Best Practices for Timely Diagnosis and Optimal Management of Idiopathic Hypersomnia
FINDINGS FROM THE AMCP MARKET INSIGHTS PROGRAM | September, 2025
Idiopathic hypersomnia (IH) is a chronic, neurologic disorder with a primary symptom of excessive daytime sleepiness. There are challenges to timely, accurate diagnosis of IH and, therefore, to optimal management. To better understand these challenges and identify opportunities, AMCP Market Insights virtually convened an expert panel of managed care stakeholders in April 2024. Key insights from the discussion related to addressing diagnostic challenges in IH, making coverage decisions for medications used in IH, and implementing coverage criteria for medications used in IH. Suggested payer best practices in IH also emerged from the discussion.
For more disease state research, view the Market Insights Program.
Related
Share your research in a whole new way with AMCP ePosters powered by Digital Health Outcomes (DHO). Turn your poster into an interactive digital experience that goes beyond the conference floor—complete with live data, clickable features, and year-round visibility on the AMCP eModel Hub.
In June, the Academy of Managed Care Pharmacy (AMCP) convened leading experts from across health care disciplines for a two-day Precision Medicine Partnership Forum. The forum aimed to advance equitable and timely access to precision medicine, particularly in oncology.
Featured News & Resources
See Full CalendarUpcoming Events
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
